Clinical Trials List
2023-09-30 - 2026-06-30
Phase I
Recruiting3
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
TaiRx, Inc.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- 連銘瑜 Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jia-Ruey Tsai Division of Hematology & Oncology
- Kai-Ling Lee Division of Thoracic Medicine
- Sheng-Yu Chen Division of Hematology & Oncology
- Huan-Tze Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃盈慈 Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
